# Safety and Efficacy of Injection of Human Placenta Mesenchymal Stem Cells Derived Exosomes for Treatment of Complex Anal Fistula

> **NCT05402748** · PHASE1,PHASE2 · UNKNOWN · sponsor: **Tehran University of Medical Sciences** · enrollment: 80 (estimated)

## Conditions studied

- Fistula Perianal

## Interventions

- **OTHER:** placenta-MSCs derived exosomes

## Key facts

- **NCT ID:** NCT05402748
- **Lead sponsor:** Tehran University of Medical Sciences
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-12-22
- **Primary completion:** 2022-12-22
- **Final completion:** 2023-03-22
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2022-11-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05402748

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05402748, "Safety and Efficacy of Injection of Human Placenta Mesenchymal Stem Cells Derived Exosomes for Treatment of Complex Anal Fistula". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT05402748. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*